AU779881C - Quinuclidine derivates and their use as muscarinic M3 receptor ligands - Google Patents

Quinuclidine derivates and their use as muscarinic M3 receptor ligands

Info

Publication number
AU779881C
AU779881C AU64330/00A AU6433000A AU779881C AU 779881 C AU779881 C AU 779881C AU 64330/00 A AU64330/00 A AU 64330/00A AU 6433000 A AU6433000 A AU 6433000A AU 779881 C AU779881 C AU 779881C
Authority
AU
Australia
Prior art keywords
quinuclidine
muscarinic
derivates
receptor ligands
ligands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
AU64330/00A
Other versions
AU6433000A (en
AU779881B2 (en
Inventor
Maria Antonia Buil Albero
Dolors Fernandez Forner
Maria Prat Quinones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almirall SA
Original Assignee
Almirall SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES009901580A external-priority patent/ES2165768B1/en
Application filed by Almirall SA filed Critical Almirall SA
Publication of AU6433000A publication Critical patent/AU6433000A/en
Assigned to ALMIRALL PRODESFARMA AG reassignment ALMIRALL PRODESFARMA AG Alteration of Name(s) of Applicant(s) under S113 Assignors: ALMIRALL PRODESFARMA S.A.
Publication of AU779881B2 publication Critical patent/AU779881B2/en
Application granted granted Critical
Priority to AU2005202144A priority Critical patent/AU2005202144B2/en
Assigned to ALMIRALL AG reassignment ALMIRALL AG Request to Amend Deed and Register Assignors: ALMIRALL PRODESFARMA AG
Assigned to LABORATORIOS ALMIRALL, S.A. reassignment LABORATORIOS ALMIRALL, S.A. Alteration of Name(s) in Register under S187 Assignors: ALMIRALL AG
Assigned to ALMIRALL, S.A. reassignment ALMIRALL, S.A. Request to Amend Deed and Register Assignors: LABORATORIOS ALMIRALL, S.A.
Publication of AU779881C publication Critical patent/AU779881C/en
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

AU64330/00A 1999-07-14 2000-07-07 Quinuclidine derivates and their use as muscarinic M3 receptor ligands Active 2025-07-07 AU779881C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2005202144A AU2005202144B2 (en) 1999-07-14 2005-05-18 Quinuclidine derivatives and their use as muscarinic M3 receptor ligands

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES009901580A ES2165768B1 (en) 1999-07-14 1999-07-14 NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ES9901580 1999-07-14
PCT/EP2000/006469 WO2001004118A2 (en) 1999-07-14 2000-07-07 Quinuclidine derivatives and their use as muscarinic m3 receptor ligands

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2005202144A Division AU2005202144B2 (en) 1999-07-14 2005-05-18 Quinuclidine derivatives and their use as muscarinic M3 receptor ligands

Publications (3)

Publication Number Publication Date
AU6433000A AU6433000A (en) 2001-01-30
AU779881B2 AU779881B2 (en) 2005-02-17
AU779881C true AU779881C (en) 2015-05-07

Family

ID=

Similar Documents

Publication Publication Date Title
ZA200200232B (en) Quinuclidine derivatives and their use as muscarinic M3 receptor ligands.
EP1212327B8 (en) Pyrazolopyrimidines as therapeutic agents
AU4368100A (en) Proning bed
AU6103000A (en) Compounds with activity on muscarinic receptors
AP2002002441A0 (en) Arylmethyl-carbonyla minothiazole derivates and their use as antitumor agents
HUP0203514A3 (en) Quinuclidine compounds and drugs containing them and process for preparation the same
EP1106426A3 (en) Rotatable headrest
AU2002212213A1 (en) Pigment preparation in granulate form
EP1170020A4 (en) Patches for external use
AU2002235224A1 (en) Muscarinic antagonists
AU4923200A (en) Isothiazolecarboxamides and their use as microbicides
AU7377200A (en) Combination therapy including camptothecin
AU2001287114A1 (en) Aryl substituted tetrahydroindazoles and their use as ligands for the gaba-a receptor
AU1948601A (en) Triazospiro compounds having nociceptin receptor affinity
AU5319700A (en) Nicotine receptor ligands
AU5851100A (en) Steering device
AU5786300A (en) Muscarinic antagonists
AU3991595A (en) Muscarinic receptor ligands
AU4781100A (en) Ip3 receptor ligands
AU4818600A (en) Ionomeric particulate composition
AU4957300A (en) Filter device
AU6913100A (en) Notch receptor ligands and uses thereof
AU2998700A (en) Organosilicon compounds and uses thereof
AU6016000A (en) Tricyclic compounds and drug compositions containing the same
AU779881C (en) Quinuclidine derivates and their use as muscarinic M3 receptor ligands